Novolin 70/30 is an insulin medication approved for the treatment of diabetes in adults. This eMedTV article describes the effects of this medication, explains when and how to inject it, lists potential side effects that may occur, and more.
Potential Novolin 70/30 side effects include skin reactions at the injection site and low blood sugar. This eMedTV page also lists serious side effects that require medical attention, such as diabetic ketoacidosis or dangerously low blood sugar.
Novolin 70/30 is used for controlling blood sugar levels in adults with diabetes. This page from the eMedTV library discusses these uses in more detail, including information on possible off-label uses and an explanation of how Novolin 70/30 works.
Your doctor will recommend your Novolin 70/30 dosage based on your blood sugar levels and other factors. This eMedTV page lists other factors that may help determine Novolin 70/30 dosing and offers tips and precautions for those using this drug.
Fluoxetine, fibrates, and MAOIs are some of the medicines that may cause Novolin 70/30 drug interactions. As this eMedTV resource explains, drug interactions such as these can result in dangerously low blood sugar levels, which can be fatal.
Low blood sugar is the most common (and usually most serious) side effect of Novolin 70/30. This eMedTV segment contains other Novolin 70/30 warnings and precautions, including information on who should not use this insulin medication.
A Novolin 70/30 overdose can result in low blood sugar levels. This article from the eMedTV archives lists symptoms of low blood sugar, explains how an overdose may occur, and describes various treatment options for a Novolin 70/30 overdose.
Novolin 70/30 is generally considered safe for use during pregnancy. This part of the eMedTV Web site offers a more in-depth look at Novolin 70/30 and pregnancy, and explains whether insulin products cross the placenta.
Breastfeeding can affect your blood sugar and, consequently, your insulin requirements. This eMedTV segment provides more details on Novolin 70/30 and breastfeeding, including information on whether this product passes through breast milk.
Laws currently prevent any generic versions of Novolin 70/30 from being made in the United States. This eMedTV Web page explains why these laws are in place and explores when generic forms of insulin may become available.
